Jim Sales is of counsel in the Bose McKinney & Evans Intellectual Property Group. He has practiced as a patent attorney since 1989, focusing in the pharmaceutical, biopharmaceutical, animal health and chemical areas. Jim’s practice includes client counseling for global strategic patent portfolio and lifecycle development, U.S. international patent drafting and prosecution, IP due diligence, transactions and contracts, and opinions for patentability, validity and freedom to operate.
He was in-house counsel for Eli Lilly and Company for over 14 years, in various capacities, including director of European patent operations. During his tenure at Eli Lilly and Company, Jim focused on client counseling for pharmaceutical research and development, and marketing teams along the entire development timeline, including post-launch product teams and teams in early development. His experience there included global patent portfolio and exclusivity creation, legal opinions, product life-cycle planning, Hatch-Waxman litigation strategy and support, transactional work, international patent procurement and enforcement, as well as considerable managerial experience. Jim was also General Patent Counsel for JohnsonDiversey, Inc. in Wisconsin. His responsibilities there included global intellectual patent management, including development and implementation of overall company intellectual property strategies and policies; patent portfolio management; in and out licensing of intellectual property; litigation management; acquisitions/dispositions, intellectual property due diligence; management of IP group; and budgeting.
He lectures on various intellectual property matters, including at American Chemical Society and IQPC meetings.
